Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT03062488 · ClinicalTrials.gov registry record · Early Phase 1

Emergence Agitation and Pain Scores in Pediatrics When Comparing Single-modal vs Multi-modal Analgesia for ENT Surgery

A Early Phase 1 study of Pain and Emergence Agitation, sponsored by Nemours Children's Clinic.

Completed
Registry status
Early Phase 1
Development phase
143
Enrollment target
1
Study location

NCT03062488: Completed Early Phase 1 study of Pain and Emergence Agitation, sponsored by Nemours Children's Clinic.

NCT03062488 is a Early Phase 1 study of Pain and Emergence Agitation that has completed, run by Nemours Children's Clinic. The registered enrollment target is 143 participants, below the 304-participant average among 374 other Pain trials with a reported enrollment target (53% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT03062488, a Early Phase 1 study of Pain and Emergence Agitation, has completed, sponsored by Nemours Children's Clinic.

COMPLETED
Registry status
Early Phase 1
Development phase
143 participants
Enrollment target
1
Study location

Study Summary

The purpose of this study is to compare the incidence of EA in pediatric patients undergoing minor ENT surgery under Sevoflurane and compare opioid-only based intra-operative analgesia to multi-modal analgesia consisting of opioid and IV acetaminophen or PO acetaminophen regimen using a validated and standardized EA measurement tool, the Pediatric Anesthesia Emergence Delirium (PAED) scale. The post operative pain scores will be measured in all patients by post-op recovery staff using FLACC Score/Wong-Baker FACES (patients 24 months up to 7 years of age) or Numeric Pain Score for patients 7 years of age. The pre-operative, surgery, anesthesia and post-operative staff will be all blinded.

Primary Outcome

Post Anesthesia Emergence Delirium (PAED) Scale 0 - 20. EA defined as a score equal or greater than 12

Conditions Studied

Interventions

  • DRUG Fentanyl
  • DRUG IV acetaminophen
  • DRUG PO acetaminophen

Study Locations (1)

Florida

  • Nemours Children's Specialty Care - Jacksonville

Trial Details

FieldValue
Enrollment Target 143 participants
Start Date 2017-10-03
Est. Completion 2018-07-11
Phase Early Phase 1
Nemours Children's Clinic

108 total trials

What the finished NCT03062488 record still lists

NCT03062488 is an interventional study that assigns participants to a tested intervention. The registered 143 participants enrollment target is mid-sized for trials with a published cap, below the 304-participant average among 374 other Pain trials with a reported enrollment target (53% lower).

The record links to 2 conditions, with Pain appearing as the primary indexed condition, and to 3 interventions - of which Fentanyl is the first listed.

NCT03062488 reports a single indexed study location in Florida.

Frequently Asked Questions

What is clinical trial NCT03062488 about?

NCT03062488 is a clinical study titled "Emergence Agitation and Pain Scores in Pediatrics When Comparing Single-modal vs Multi-modal Analgesia for ENT Surgery". The purpose of this study is to compare the incidence of EA in pediatric patients undergoing minor ENT surgery under Sevoflurane and compare opioid-only based intra-operative analgesia to multi-modal analgesia consisting of opioid and IV acetaminophen or PO acetaminophen regimen using a validated an...

What is the current status of trial NCT03062488?

This trial is currently completed. It is a Early Phase 1 study. The enrollment target is 143 participants. The study started on 2017-10-03. Estimated completion is 2018-07-11.

What conditions does trial NCT03062488 study?

This clinical trial studies the following conditions: Pain, Emergence Agitation.

What interventions are being tested in trial NCT03062488?

The interventions under investigation include: Fentanyl (DRUG), IV acetaminophen (DRUG), PO acetaminophen (DRUG).

Who is sponsoring clinical trial NCT03062488?

This trial is sponsored by Nemours Children's Clinic, which has 108 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT03062488 being conducted?

This trial has 1 study location across Florida. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Pain

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT03062488's enrollment target sits among peer trials

143 121st of 374 higher than 254 of 374 other Pain trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Pain trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT01861106 · 144 participants · Phase 2

    Allogeneic Hematopoietic Stem Cell Transplant for GATA2 Mutations

  • NCT03482245 · 144 participants · NA

    The Role of Circadian Clock Proteins in Innate and Adaptive Immunity

  • NCT03504683 · 144 participants · NA

    MEAL TIMING Study: Effect of Time-Restricted Feeding on 24-hour Glycemic Control, Blood Pressure, and Cardiovascular Disease Risk Factors in Adults With Prediabetes

  • NCT03905603 · 144 participants · Early Phase 1

    Relative Contributions of Predictors of Hyperandrogenism in Older vs. Young Women With PCOS

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT03062488, the US trial registry maintained by the National Library of Medicine. NCT03062488 (mid enrollment · single site footprint · completed) retrieved and formatted by PlainTrial, see methodology.